128 filings
Page 3 of 7
8-K
wk2o0d6itd
8 Jun 22
Submission of Matters to a Vote of Security Holders
5:23pm
8-K
r8oowi9x1n 0w8o
12 May 22
Panbela Provides Business Update and Reports Q1 2022 Financial Results
4:07pm
8-K
78fuh nvw
24 Mar 22
Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results
4:06pm
8-K
obb 6u67gz8yn7w6
22 Feb 22
Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
8:03am
8-K
a1r xsjsd
10 Nov 21
Panbela Provides Business Update and Reports Q3 2021 Financial Results
4:16pm
8-K
xu50hbf
11 Aug 21
Panbela Provides Business Update and Reports Q2 2021 Financial Results
4:13pm
8-K
po73xoma8nfxkr2msuy
2 Jul 21
Panbela Therapeutics Announces $5.0 Million Bought Deal Offering of Common Stock
4:06pm
8-K
sr61ee3xj6u
21 Jun 21
Regulation FD Disclosure
8:00am
8-K
nyua6bjjp68riwhkm4k
16 Jun 21
Regulation FD Disclosure
8:00am
8-K
32c08tqk
4 Jun 21
Regulation FD Disclosure
9:16am
8-K
kjl2tigxqd9jaovgm2r
26 May 21
Panbela Announces Company Founder Dr. Michael T. Cullen to Serve as Chairman of the Board of Directors
8:03am
8-K
w0s2wnjo
12 May 21
Panbela Provides Business Update and Reports Q1 2021 Financial Results
4:11pm
8-K
uh0ydpv
15 Apr 21
Panbela Announces Partial Clinical Hold Lifted on Phase I Polyamine Metabolic Inhibitor Study in Pancreatic Cancer
8:05am
8-K/A
rc9dpn066 7lj
26 Mar 21
Results of Operations and Financial Condition
8:40am
8-K
p79hysrg
25 Mar 21
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
12:00am
8-K
zqoau aqmf0t5d
10 Feb 21
Regulation FD Disclosure
8:45am
8-K
mbhkwpim
8 Dec 20
Regulation FD Disclosure
8:01am
8-K
a68s2ril z4t3zuargmy
2 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:55pm
8-K
jgzk5yv6
12 Nov 20
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results
4:11pm
8-K
2q1tksbi76
14 Sep 20
Regulation FD Disclosure
8:00am